DIG
TRAW icon

Dauntless Investment Group’s Traws Pharma TRAW Stock Holding History

Dauntless Investment Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$763K Buy
+416,998
New +$784K 0.51% 24

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Dauntless Investment Group's TRAW Position: Q1 2026 in Review

Dauntless Investment Group opened a new position in Traws Pharma (TRAW) in Q1 2026: 416,998 shares worth $763K. The stake represents 0.51% of the portfolio and ranks #24 among its holdings.

28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Dauntless Investment Group held 416,998 shares of Traws Pharma worth $763K as of Q1 2026.
  • Traws Pharma was a new Dauntless Investment Group position in Q1 2026.
  • Traws Pharma made up 0.51% of Dauntless Investment Group's portfolio in Q1 2026, its #24 holding.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.